150 related articles for article (PubMed ID: 14576953)
1. Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women.
Sadan O; Schejter E; Ginath S; Bachar R; Boaz M; Menczer J; Glezerman M
Arch Gynecol Obstet; 2004 Mar; 269(3):188-91. PubMed ID: 14576953
[TBL] [Abstract][Full Text] [Related]
2. Screening for Cervical Cancer Among Low-Risk Populations: Orthodox Jewish Women as a Model.
Caspi R; Schejter E; Groutz A
J Womens Health (Larchmt); 2016 Jul; 25(7):747-51. PubMed ID: 26599257
[TBL] [Abstract][Full Text] [Related]
3. Cervical Pap screening among Israeli women, 2005-2010.
Bassal R; Schejter E; Bachar R; Shapira H; Sandbank J; Supino Rosin L; Schvimer M; Cohen D; Keinan-Boker L
Arch Gynecol Obstet; 2014 Mar; 289(3):615-22. PubMed ID: 24085583
[TBL] [Abstract][Full Text] [Related]
4. Cervical neoplasia in Israeli Jewish women: characteristics in a low risk population.
Menczer J
Isr Med Assoc J; 2011 Nov; 13(11):700-4. PubMed ID: 22279707
[TBL] [Abstract][Full Text] [Related]
5. The Incidence and Clinical Significance of Atypical Glandular Cells of Undetermined Significance on Cervical Pap Smears.
Al-Rayyan E; Rashed M; Maaita M; Qudah S; Taso O; Haddadin W
Gulf J Oncolog; 2019 May; 1(30):52-56. PubMed ID: 31242982
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of abnormal Papanicolaou smears in female sex workers in Hong Kong.
Leung KM; Yeoh GP; Cheung HN; Fong FY; Chan KW
Hong Kong Med J; 2013 Jun; 19(3):203-6. PubMed ID: 23650200
[TBL] [Abstract][Full Text] [Related]
7. Selected clinical characteristics of Israeli Jewish women with squamous cell carcinoma of the uterine cervix: a population-based study.
Kogan L; Menczer J; Shejter E; Liphshitz I; Barchana M
Isr Med Assoc J; 2011 Feb; 13(2):84-6. PubMed ID: 21443032
[TBL] [Abstract][Full Text] [Related]
8. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high-risk human papillomavirus in women with abnormal and normal vaginal ThinPrep Papanicolaou cytology.
Bansal M; Zhao C
J Low Genit Tract Dis; 2011 Apr; 15(2):105-9. PubMed ID: 21317806
[TBL] [Abstract][Full Text] [Related]
10. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
[TBL] [Abstract][Full Text] [Related]
11. Race-specific results of Papanicolaou testing and the rate of cervical neoplasia in the National Breast and Cervical Cancer Early Detection Program, 1991-1998 (United States).
Benard VB; Lee NC; Piper M; Richardson L
Cancer Causes Control; 2001 Jan; 12(1):61-8. PubMed ID: 11227926
[TBL] [Abstract][Full Text] [Related]
12. Determination of the diagnostic accuracy of testing for high-risk (HR) human papillomavirus (HPV) types 16, 18 and 45 in precancerous cervical lesions: preliminary data.
Tiews S; Steinberg W; Schneider W; Hanrath C
J Clin Virol; 2009 Nov; 46 Suppl 3():S11-5. PubMed ID: 20129068
[TBL] [Abstract][Full Text] [Related]
13. [Cervical cancer screening by Pap smear: experience of the National Research Center in Reproductive Health. ONFP].
Ben Aissa R; Bennour R; Ben Hamida A; Kammoun N; Mansour H; Mhamdi A; Landoulsi S; Cherif N; Gueddana N
Tunis Med; 2002 Apr; 80(4):203-6. PubMed ID: 12416356
[TBL] [Abstract][Full Text] [Related]
14. [The results of screening program for cervical cancer in Lodz].
Gottwald L; Giernat L; Lech W; Wójcik-Krowiranda K; Akoel KM; Kowalczyk-Amico K; Estemberg D; Grzesiak M; Sosnowski D; Guzowski G; Baś E; Tyliński W; Bieńkiewicz A
Ginekol Pol; 2002 Nov; 73(11):934-8. PubMed ID: 12722377
[TBL] [Abstract][Full Text] [Related]
15. The inter-relationship of herpes virus, papilloma 16/18 virus infection and Pap smear pathology in Israeli women.
Isacsohn M; Dolberg L; Sabag SG; Mitrani-Rosenbaum S; Nubani N; Diamant YZ; Goldsmidt R
Isr J Med Sci; 1994; 30(5-6):383-7. PubMed ID: 8034488
[TBL] [Abstract][Full Text] [Related]
16. Low-income minority women at risk for cervical cancer: a process to improve adherence to follow-up recommendations.
Cardin VA; Grimes RM; Jiang ZD; Pomeroy N; Harrell L; Cano P
Public Health Rep; 2001; 116(6):608-16. PubMed ID: 12196621
[TBL] [Abstract][Full Text] [Related]
17. Presence of histopathological premalignant lesions and infection caused by high-risk genotypes of human papillomavirus in patients with suspicious cytological and colposcopy results: A prospective study.
Golubović M; Lopičić M; Terzić N; Đurović M; Mugoša B; Mijović G
Vojnosanit Pregl; 2017 Jan; 74(1):24-30. PubMed ID: 29350503
[TBL] [Abstract][Full Text] [Related]
18. Pap smear accuracy for the diagnosis of cervical precancerous lesions.
Nkwabong E; Laure Bessi Badjan I; Sando Z
Trop Doct; 2019 Jan; 49(1):34-39. PubMed ID: 30222058
[TBL] [Abstract][Full Text] [Related]
19. High-grade cervical abnormalities and cervical cancer in women following a negative Pap smear with and without an endocervical component: a cohort study with 10 years of follow-up.
Sultana F; English DR; Simpson JA; Canfell K; Gertig DM; Saville M
Int J Cancer; 2014 Sep; 135(5):1213-9. PubMed ID: 24488882
[TBL] [Abstract][Full Text] [Related]
20. HPV Screening Test for the Detection of Precancerous Cervical Lesions and Cervical Cancer in Israeli Women.
Feinberg T; Yehuda-Shnaidman E; Wolf T; Sandbank J; Segal J; Vaknin Z; Schejter E
Acta Cytol; 2021; 65(6):494-500. PubMed ID: 34515031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
